Chronic anti-coagulation therapy reduced mortality in patients with high cardiovascular risk early in COVID-19 pandemic

Mostrar otras versiones (1)

BACKGROUND: Coronavirus disease 2019 (COVID-19) is associated with provoked thrombo-inflammatory responses. Early in the COVID-19 pandemic this was thought to contribute to hypercoagulability and multi-organ system complications in infected patients. Limited studies have evaluated the impact of ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Zaghloul, Mohamed S., Jammeh, Momodou, Gibson, Andrew, Luo, Suhong, Chadwick-Mansker, Kelley, Liu, Qianjin, Yan, Yan, Zayed, Mohamed A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885912/
https://www.ncbi.nlm.nih.gov/pubmed/36717941
http://dx.doi.org/10.1186/s12959-023-00460-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885912/
https://www.ncbi.nlm.nih.gov/pubmed/36717941
http://dx.doi.org/10.1186/s12959-023-00460-z

Ejemplares similares